09:59 EST Kyverna Therapeutics (KYTX) Inc trading resumes
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KYTX:
- Kyverna Therapeutics Inc trading halted, volatility trading pause
- Kyverna Reports Positive Phase 2 Trial Results
- Kyverna Therapeutics Reports Positive Phase 2 Trial Results
- Kyverna Therapeutics announces topline data from registrational KYSA-8 trial
- Kyverna Therapeutics price target raised to $25 from $20 at Morgan Stanley